According to recent announcements, Lexaria has initiated a new preclinical research program designed to evaluate its DehydraTECH platform with emerging GLP 1 candidates including amycretin and retatrutide
Researchers appreciate products that combine quality, consistency, and ease of use
Neuroprotection by scatter factor/hepatocyte growth factor and FGF-1 in cerebellar granule neurons is phosphatidylinositol 3-kinase/Akt-dependent and MAPK/CREB-independent
[1] [2] When used with insulin or sulfonylureas, there is an increased risk of hypoglycaemia, and dose adjustments of these medications may be needed
In contrast to therapies that only act on a single receptor, these medications are known as dual-agonists because they activate two receptors simultaneously
Similarly, activation of mitochondrial CB 1 Rs with THC resulted in reduced glycolytic activity and lactate production in primary cultured astrocytes (01-days-old), which was hypothesized to contribute to the subsequent impaired neuronal function and altered behavior (e.g., social interaction deficit) in young adult (812-weeks-old) mice (Jimenez-Blasco et al., 2020)
